Vimarsana
Biggest News Aggregation in the World

Pharma Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Board Today - Breaking & Trending Today

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT - Vimarsana News

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR ...

Exelixis Advances Board Refreshment Plan - Vimarsana News

Exelixis Advances Board Refreshment Plan

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) (the “Company”) today announced that Carl Feldbaum, Esq. and Vincent Marchesi, M.D., Ph.D., two long-standing and valued members of the Board of Directors, will not stand for re-election at the Company’s 2023 Annual Meeting of Stockholders (the “Annual...

4D pharma : Annual Report (SEC Filing - 20-F) - Vimarsana News

4D pharma : Annual Report (SEC Filing - 20-F)

* Not for trading, but in connection with the registration of American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission. Securities registered or to be registered pursuant to Section 12(g) of the Act: None None Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report: Title of each class Ordinary Shares, nominal value £0.0025 per Share 131,467,935 Indicate by check mark if the registrant is a...

MSNBC First Look September 12, 2019 09:13:00 - Vimarsana News

MSNBC First Look September 12, 2019 09:13:00

Settlement for their hand in the opioid crisis nationwide. the agreement with top legal officials in 27 states and territories and lawyers for more than 2,000 cities and counties would require the company to declare bankruptcy, and be turned into a for profit trust. the sackler family would have to give up control of the company and turn over proceeds from the drug sales to the plaintiffs. however, the deal still needs approval from the pharma board as well as the bankruptcy court judge. the company released a statement on the deal saying this, purdue pharma continues to work on all plaintiffs...